Wu, X., Liu, P., Zhang, H., Li, Y., Salmani, J. M. M., Wang, F., . . . Chen, B. (2017). Wogonin as a targeted therapeutic agent for EBV (+) lymphoma cells involved in LMP1/NF-κB/miR-155/PU.1 pathway. BMC Cancer.
Styl cytowania ChicagoWu, Xue, et al. "Wogonin As a Targeted Therapeutic Agent for EBV (+) Lymphoma Cells Involved in LMP1/NF-κB/miR-155/PU.1 Pathway." BMC Cancer 2017.
Styl cytowania MLAWu, Xue, et al. "Wogonin As a Targeted Therapeutic Agent for EBV (+) Lymphoma Cells Involved in LMP1/NF-κB/miR-155/PU.1 Pathway." BMC Cancer 2017.
Uwaga: Te cytaty mogą odróżniać się od wytycznej twojego fakultetu..